MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 8041-8050 Newer>
The Motley Fool
November 8, 2011
Brian Orelli
This Biotech Thinks It's Cheap Amgen thinks its investors aren't valuing the company properly. It's offering to repurchase $5 billion worth of stock -- about 10% of its value -- and even willing to borrow the cash to get it done. mark for My Articles 85 similar articles
The Motley Fool
November 8, 2011
Anders Bylund
Isis Pharmaceuticals' Shares Plunged: What You Need to Know Shares of drug developer Isis Pharmaceuticals hardly looked like a model of fertility today as they fell 10.5% in heavy intraday trading. mark for My Articles 62 similar articles
The Motley Fool
November 8, 2011
Brian Wilson
2 Health-Care Stocks for Times of Uncertainty Just because Abbott and Johnson & Johnson don't undertake as much risk as other health-care giants doesn't mean that shareholders won't see impressive growth in revenues. mark for My Articles 632 similar articles
The Motley Fool
November 8, 2011
Brandon Glenn
Cardinal Health Looks to Build China Business, but Has Long Way to Go For pharmaceuticals distributor Cardinal Health, China represents a world of opportunity. mark for My Articles 39 similar articles
The Motley Fool
November 7, 2011
David Williamson
Health-Care News You Can't Afford to Miss Highlighting the day's health-care stories: FDA approval for Johnson & Johnson... Inhibitex kept its streak of double-digit gains alive with another 14% surge today... 13% plunge for Optimer Pharmaceuticals... mark for My Articles 203 similar articles
The Motley Fool
November 7, 2011
Dan Caplinger
Has Pfizer Become the Perfect Stock? The pharma giant still faces the challenge of patent expirations that could outpace its pipeline development. mark for My Articles 811 similar articles
The Motley Fool
November 5, 2011
David Williamson
Inhibitex Investors: Why Shares Popped 115% Great results for INX-189 send shares skyward. mark for My Articles 62 similar articles
The Motley Fool
November 4, 2011
Brian Orelli
You Should Have Seen These Biotech Failures Coming Micro cap biotechs are a value for a reason. mark for My Articles 137 similar articles
The Motley Fool
November 4, 2011
Anders Bylund
Optimer Pharmaceuticals Shares Dropped: What You Need to Know Shares of Optimer Pharmaceuticals, which develops advanced hospital products such as highly specialized antibiotics, fell as much as 15.7% today on very heavy trading. mark for My Articles 8 similar articles
The Motley Fool
November 4, 2011
Luke Timmerman
Celgene to Pump $45M Into Quanticel to Discover Cancer Drugs Celgene strikes an unusual agreement. mark for My Articles 96 similar articles
<Older 8041-8050 Newer>    Return to current articles.